FDA Approves Exondys51

September 19, 2016

19.09.2016-Sarepta Therapeutics Announces FDA Accelerated Approval of EXONDYS 51™ (eteplirsen) ...

Successfully accomplished/participated events (archive)

June 3, 2015

Visit the link to glance through a list of events organized/represented by Muscular Dystrophy Founda ...

Orphan Medicinal Product Designation for CAT - 1004

October 26, 2015

European Commission grants Orphan Medicinal Product designation for CAT-1004, Catabasis Pharmaceutic ...

Orphan Drug Designation for ARM210/S48168

December 9, 2015

ARMGO Pharma Receives FDA Orphan Drug Designation and Rare Pediatric Disease Designation for ARM210/ ...

Santhera Reports New Data for Raxone® (idebenone)

November 11, 2015

Santhera Reports New Data and Updates on Regulatory Filings for Raxone® (idebenone) in Duchenne ...

FDA Advisory Committee to Review Drisapersen

November 24, 2015

BioMarin Announces FDA Advisory Committee to Review Drisapersen for Treatment of Patients With Duche ...

Registration open for a residential program of rehabilitation & training

05/12/2015

Muscular Dystrophy Resource Center is currently admitting DMD children for a complete rehabilitation ...